Tesla Vision Corporation (TSLV)

[wafflestomper]

ADMD under scrutiny....

http://qurl.com/b9mc8

ADVANCED MEDICAL ISOTOPE CORP

Pinnacle Digest: Memorandum Signed Spurs Review: Sector Specific
3/28/2007

Mar 28, 2007 (M2 PRESSWIRE via COMTEX News Network) --
To read this article in its entirety, visit www.pinnacledigest.com.

Advanced Medical Isotopes Corporation (OTC:PK:ADMD) experienced a significant loss in share value Tuesday, falling 12.50% along with 66,130 shares traded. They recently announced the signing of a Memorandum of Understanding with Kadlec Medical Center as a precursor step to formal contract discussions for the supply of short-lived radio-isotopes primarily used in Positron Emission Tomography(PET) and other diagnostic imaging applications. This has spurred a progressive review by PinnacleDigest. We are closely reviewing this company's recent news in respect to the major movements within the healthcare sector. To read this article in full and to learn more about our expanding, diverse online financial magazine, visit us at www.pinnacledigest.com.

The IT side of managing and delivering healthcare has emerged to the forefront of the healthcare industry and will guide its future advancement. InnerWireless and PanGo Networks announced last week their merger. Both of these company's hold major stakes in the healthcare IT market. This is a trend that is sweeping the country and world as hospitals and healthcare institutions are adapting to make operations efficient.

InnerWireless provides wireless coverage inside large buildings, most notably hospitals and commercial and government facilities. They have also recently launched Spot, a real-time tracking system that keeps track of hospital assets, patients and staff.

California's stem cell agency is in the news after awarding 29 research grants totaling a colossal $74.6 million to non-profit California institutions and universities. As the world progresses with stem cell research, the state of California is the single largest source of funds for embryonic stem-cell research in the world. A company based out of Baltimore, Osiris Therapeutics has recently been in the news documenting their easy to administer stem cell treatment in respect to heart attack patients. After a recent study the treatment reportedly helped patients recover after a heart attack as well as easing their symptoms. This company is moving forward in this area, intending to conduct studies of adult stem cell-based products to treat diseased hearts. PinnacleDigest will be reviewing the issue and coming back to the major grants awarded documenting the companies involved and the overall potential created by these grants.

Let's turn back to Advanced Medical Isotopes Corporation and learn more about their recently signed memorandum. The CEO of Advanced Medical Isotopes William Stokes had this to say following the announcement, "This arrangement with Kadlec Medical Center as our anchor customer is a fantastic opportunity for our company and our local area for the continued development of a Tri-Cites based isotope industry. We want to expressly thank Kadlec's willingness to support a local company and allows AMIC to continue our agenda for the utilization of the vast knowledge and expertise in our scientific community." PinnacleDigest will be awaiting further corporate developments from this company as well as the integration of this new factor. To follow up with Advanced Medical Isotopes and learn more about the sector influencing this company, come explore our expanding, diverse online financial magazine at www.pinnacledigest.com.

To continue with this report as well as other related articles, please visit www.pinnacledigest.com for a complimentary membership. It should be stated that our membership requires no commitment to our service. If you would like to contact us please write to [e-mail].

PinnacleDigest has no vested interest in the company mentioned herein. This source of information is from an unbiased perspective. If you wish to become a member of www.pinnacledigest.com you will be gaining access to articles similar to this one and many other useful services we know you will find valuable. Keeping you educated and up-to-date with the market is one of our main purposes. Our approach in achieving this goal and our ability to consistently deliver high quality investment material is what defines our business model.

Investors seeking a distinctive approach to investing should also visit www.pinnacledigest.com for a complimentary membership.

About Pinnacle Digest

Pinnacledigest.com is an emerging online financial newsletter community. We put together informative material, capturing the information that we know will give you an edge to your portfolio and more specifically your investment approach.

Once a member of PinnacleDigest you will be able to access our complimentary full-length research reports on selected companies, our weekly volumes, and our market overviews. In addition to these services we are confident you will enjoy our many other services, as well as our main feature which is available to all our members.

We pride ourselves in having a multi purpose online magazine and encourage you to join our community.

This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.

All material herein was prepared by Pinnacledigest.com (Pinnacle Digest) based upon information believed to be reliable. The information contained herein is not guaranteed by Pinnacledigest.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Pinnacledigest.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Pinnacledigest.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.

Pinnacledigest.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Pinnacledigest.com undertakes no obligation to update such statements.

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [e-mail].

(C)1994-2007 M2 COMMUNICATIONS LTD